Glaucoma device study ends early: what we learned
NCT ID NCT06230393
First seen Apr 04, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study looked at the long-term safety and effectiveness of the STREAMLINE® Surgical System in people with open-angle glaucoma who had already taken part in an earlier trial. The goal was to see if the device continues to lower eye pressure safely over time. Only 17 people enrolled, and the study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica 20/20
San José, Costa Rica
Conditions
Explore the condition pages connected to this study.